Showing results (131-140 of 171) with videos related to
Sort By:
Pageof 18
Cancer Discovery|November 11, 2017
Genetic Predictors of Response to Systemic Therapy in Esophagogastric CancerYelena Y Janjigian, Francisco Sanchez-Vega, Philip Jonsson, et al.Journal of Gastrointestinal Oncology|August 27, 2016
Use of positron emission tomography scan response to guide treatment change for locally advanced gastric cancer: the Memorial Sloan Kettering Cancer Center experienceElizabeth Won, Manish A Shah, Heiko Schöder, et al.Cancer Immunity|June 6, 2009
Safety and immunogenicity of a human and mouse gp100 DNA vaccine in a phase I trial of patients with melanomaJianda Yuan, Geoffrey Y Ku, Humilidad F Gallardo, et al.Future Oncology (London, England)|February 20, 2019
KEYNOTE-585: Phase III study of perioperative chemotherapy with or without pembrolizumab for gastric cancerYung-Jue Bang, Eric Van Cutsem, Charles S Fuchs, et al.JAMA Oncology|October 11, 2019
Efficacy and Safety of Trifluridine/Tipiracil Treatment in Patients With Metastatic Gastric Cancer Who Had Undergone Gastrectomy: Subgroup Analyses of a Randomized Clinical TrialDavid H Ilson, Josep Tabernero, Aliaksandr Prokharau, et al.Annals of Surgical Oncology|December 5, 2002
Radical resection of rectal cancer primary tumor provides effective local therapy in patients with stage IV diseaseGarrett M Nash, Leonard B Saltz, Nancy E Kemeny, et al.Practical Radiation Oncology|November 3, 2023
The Society of Thoracic Surgeons/American Society for Radiation Oncology Updated Clinical Practice Guidelines on Multimodality Therapy for Locally Advanced Cancer of the Esophagus or Gastroesophageal JunctionStephanie G Worrell, Karyn A Goodman, Nasser K Altorki, et al.The Annals of Thoracic Surgery|November 3, 2023
The Society of Thoracic Surgeons/American Society for Radiation Oncology Updated Clinical Practice Guidelines on Multimodality Therapy for Locally Advanced Cancer of the Esophagus or Gastroesophageal JunctionStephanie G Worrell, Karyn A Goodman, Nasser K Altorki, et al.Cancer Immunity|January 8, 2010
Correlation of clinical and immunological data in a metastatic melanoma patient with heterogeneous tumor responses to ipilimumab therapyJianda Yuan, David B Page, Geoffrey Y Ku, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2023
ILUSTRO: Phase II Multicohort Trial of Zolbetuximab in Patients with Advanced or Metastatic Claudin 18.2-Positive Gastric or Gastroesophageal Junction AdenocarcinomaSamuel J Klempner, Keun-Wook Lee, Kohei Shitara, et al.Pageof 18